
Crescent Biopharma prices $125M public offering of shares and pre-funded warrants
Crescent Biopharma announced the pricing of its public offering of 8.09 million ordinary shares and pre-funded warrants for 525,897 shares at about $14.50 each, aiming to raise approximately $125 million before expenses. The offering includes a 30-da...


